![Annkristin HEINE | Medical Doctor | Professor | University of Bonn - Medical Center, Bonn | Haematology Oncology | Research profile Annkristin HEINE | Medical Doctor | Professor | University of Bonn - Medical Center, Bonn | Haematology Oncology | Research profile](https://www.researchgate.net/publication/352759041/figure/fig2/AS:1038802890002447@1624681317700/delalisib-affects-proliferation-of-allogeneic-T-cells-in-a-DCdependent-manner-A-Schematic_Q320.jpg)
Annkristin HEINE | Medical Doctor | Professor | University of Bonn - Medical Center, Bonn | Haematology Oncology | Research profile
![PDF) Long-term survival after vaccination with RNA coding for TAA in Renal Cell Carcinoma: update on survival and correlation with immunological response PDF) Long-term survival after vaccination with RNA coding for TAA in Renal Cell Carcinoma: update on survival and correlation with immunological response](https://i1.rgstatic.net/publication/293531074_Long-term_survival_after_vaccination_with_RNA_coding_for_TAA_in_Renal_Cell_Carcinoma_update_on_survival_and_correlation_with_immunological_response/links/584ee0cf08aecb6bd8d02367/largepreview.png)
PDF) Long-term survival after vaccination with RNA coding for TAA in Renal Cell Carcinoma: update on survival and correlation with immunological response
Ann-Kristin Müller – Stellvertretende Niederlassungsleiterin – Heine + Beisswenger Gruppe | LinkedIn
![Clinical and immunological effects of mRNA vaccines in malignant diseases | Molecular Cancer | Full Text Clinical and immunological effects of mRNA vaccines in malignant diseases | Molecular Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12943-021-01339-1/MediaObjects/12943_2021_1339_Fig2_HTML.png)
Clinical and immunological effects of mRNA vaccines in malignant diseases | Molecular Cancer | Full Text
![Frontiers | Case report: Complete response to pembrolizumab in a liver metastatic colon adenocarcinoma patient with a novel likely pathogenic germline MSH2 mutation Frontiers | Case report: Complete response to pembrolizumab in a liver metastatic colon adenocarcinoma patient with a novel likely pathogenic germline MSH2 mutation](https://www.frontiersin.org/files/Articles/1064488/fimmu-13-1064488-HTML-r1/image_m/fimmu-13-1064488-g001.jpg)
Frontiers | Case report: Complete response to pembrolizumab in a liver metastatic colon adenocarcinoma patient with a novel likely pathogenic germline MSH2 mutation
![Dexamethasone induced inhibition of Dectin-1 activation of antigen presenting cells is mediated via STAT-3 and NF-κB signaling pathways | Scientific Reports Dexamethasone induced inhibition of Dectin-1 activation of antigen presenting cells is mediated via STAT-3 and NF-κB signaling pathways | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-017-04558-z/MediaObjects/41598_2017_4558_Fig1_HTML.jpg)